Bioxcel Therapeutics Logo

Latest News

VIEW ALL NEWS
Aug 28, 2026
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva PharmaceuticalsVIEW RELEASE
May 28, 2026
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual MeetingVIEW RELEASE
May 15, 2026
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial ResultsVIEW RELEASE
VIEW ALL NEWS

Stock Information

BioXcel Therapeutics, Inc.

Aug 28, 2026 04:00 PM

MARKET/SYMBOL

Nasdaq:

BTAI

PRICE

0.18

CHANGE

-0.54 (-74.76%)
EVENTS
SIGN UP FOR EMAIL ALERTS
Scroll to Top

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.